1W12
UROKINASE TYPE PLASMINOGEN ACTIVATOR
Summary for 1W12
Entry DOI | 10.2210/pdb1w12/pdb |
Related | 1C5W 1C5X 1C5Y 1C5Z 1EJN 1F5K 1F5L 1F92 1FV9 1GI7 1GI8 1GI9 1GJ7 1GJ8 1GJ9 1GJA 1GJB 1GJC 1GJD 1KDU 1LMW 1O3P 1OWD 1OWE 1OWH 1OWI 1OWJ 1OWK 1SQA 1SQO 1SQT 1URK 1W0Z 1W10 1W11 1W13 1W14 |
Descriptor | UROKINASE-TYPE PLASMINOGEN ACTIVATOR, N-((1S)-4-{[AMINO(IMINO)METHYL]AMINO}-1-FORMYLBUTYL)-2-{(3R)-3-[(BENZYLSULFONYL)AMINO]-2-OXO-5-PHENYL-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN-1-YL}ACETAMIDE (3 entities in total) |
Functional Keywords | urokinase, hydrolase, plasminogen activator |
Biological source | HOMO SAPIENS |
Total number of polymer chains | 1 |
Total formula weight | 28450.38 |
Authors | Jacob, U. (deposition date: 2004-06-15, release date: 2008-05-20, Last modification date: 2019-05-22) |
Primary citation | Zeslawska, E.,Jacob, U.,Schweinitz, A.,Coombs, G.,Bode, W.,Madison, E. Crystals of Urokinase Type Plasminogen Activator Complexes Reveal the Binding Mode of Peptidomimetic Inhibitors. J.Mol.Biol., 328:109-, 2003 Cited by PubMed: 12684001DOI: 10.1016/S0022-2836(03)00267-5 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report